Clinical Trials Browser

Phase 2 × Has results × Hematopoietic Stem Cell Mobilization × Clear all

NCT02441686 2026-01-13

Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple Myeloma

Phase 2 Completed

46 enrolled 13 charts

Multiple Myeloma

NCT02375555 2024-10-01

Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM

Phase 2 Completed

40 enrolled 18 charts

Multiple Myeloma